Board Member Thomas Lehrich Attends 2026 INCA Delegate Conference

AMEND USA was proud to attend the 14th International Neuroendocrine Cancer Alliance Global NET Patient Advocate Summit in Sofia, Bulgaria, on September 7th 2026, with Thomas Lehrich representing AMEND USA as a delegate. The summit brought together more than 30 organizations from around the world to share experiences, best practices, and ideas for strengthening NET awareness, and patient-driven research.

Thomas discussed AMEND USA’s strategy and collaboration with the medical community, and presented examples of joint educational activities with the American Association of Endocrine Surgeons. He also provided his prediction of the future of biomarkers and the use of biological materials. We are grateful for the opportunity to connect with fellow advocates globally and look forward to future ventures together.